Evidence map›Paper›PMID 37087471›Full record

ArticleCell death discovery2023

PARP1 mediated PARylation contributes to myogenic progression and glucocorticoid transcriptional response.

Arnold Tan, Awais Z Younis, Alexander Evans, Jade V Creighton, Clare Coveny, David J Boocock, Craig Sale, Gareth G Lavery, Amanda S Coutts, Craig L Doig

Open access · goldAbstract read
In one paragraph

Article in Cell death discovery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Arnold TanSchool of Science and Technology, Department of Biosciences, Nottingham Trent University, Nottingham, NG11 8NS, UK.ORCID http://orcid.org/0000-0002-8111-803X
Awais Z YounisSchool of Science and Technology, Department of Biosciences, Nottingham Trent University, Nottingham, NG11 8NS, UK.
Alexander EvansSchool of Science and Technology, Department of Biosciences, Nottingham Trent University, Nottingham, NG11 8NS, UK.
Jade V CreightonSchool of Science and Technology, Department of Biosciences, Nottingham Trent University, Nottingham, NG11 8NS, UK.
Clare CovenyJohn van Geest Cancer Research Centre, Nottingham Trent University, Nottingham, NG11 8NS, UK.
David J BoocockJohn van Geest Cancer Research Centre, Nottingham Trent University, Nottingham, NG11 8NS, UK.ORCID http://orcid.org/0000-0002-7333-3549
Craig SaleInstitute of Sport, Manchester Metropolitan University, Manchester, M1 7EL, UK.
Gareth G LaverySchool of Science and Technology, Department of Biosciences, Nottingham Trent University, Nottingham, NG11 8NS, UK.
Amanda S CouttsSchool of Science and Technology, Department of Biosciences, Nottingham Trent University, Nottingham, NG11 8NS, UK.ORCID http://orcid.org/0000-0002-5005-1864
Craig L DoigSchool of Science and Technology, Department of Biosciences, Nottingham Trent University, Nottingham, NG11 8NS, UK. craig.doig@ntu.ac.uk.ORCID http://orcid.org/0000-0001-9694-4230
Nottingham Trent University · GBManchester Metropolitan University · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The ADP-ribosyltransferase, PARP1 enzymatically generates and applies the post-translational modification, ADP-Ribose (ADPR). PARP1 roles in genome maintenance are well described, but recent work highlights roles in many fundamental processes including cellular identity and energy homeostasis. Herein, we show in both mouse and human skeletal muscle cells that PARP1-mediated PARylation is a regulator of the myogenic program and the muscle transcriptional response to steroid hormones. Chemical PARP1 modulation impacts the expression of major myocellular proteins, including troponins, key in dictating muscle contractile force. Whilst PARP1 in absence of DNA damage is often assumed to be basally inactive, we show PARylation to be acutely sensitive to extracellular glucose concentrations and the steroid hormone class, glucocorticoids which exert considerable authority over muscle tissue mass. Specifically, we find during myogenesis, a transient and significant rise in PAR. This early-stage differentiation event, if blocked with PARP1 inhibition, reduced the abundance of important muscle proteins in the fully differentiated myotubes. This suggests that PAR targets during early-stage differentiation are central to the proper development of the muscle contractile unit. We also show that reduced PARP1 in myoblasts impacts a variety of metabolic pathways in line with the recorded actions of glucocorticoids. Currently, as both regulators of myogenesis and muscle mass loss, glucocorticoids represent a clinical conundrum. Our work goes on to identify that PARP1 influences transcriptional activation by glucocorticoids of a subset of genes critical to human skeletal muscle pathology. These genes may therefore signify a regulatory battery of targets through which selective glucocorticoid modulation could be achieved. Collectively, our data provide clear links between PARP1-mediated PARylation and skeletal muscle homeostatic mechanisms crucial to tissue mass maintenance and endocrine response.

Identifiers

PMID37087471
PMCPMC10121420
OpenAlexW4366769160

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.